ID   LeCa 19.4
AC   CVCL_1E34
SY   LeCa 19-4; 19.4; LeCa, strain 19-4; LeCa Str 19-4; M-7
DR   Wikidata; Q54902429
RX   CelloPub=CLPUB00255;
RX   CelloPub=CLPUB00474;
RX   PubMed=1127734;
RX   PubMed=5487065;
CC   Doubling time: 38 hours (PubMed=1127734).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_1E35 ! LeCa 26.5
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 24-05-19; Version: 5
//
RX   CelloPub=CLPUB00255;
RA   Romsdahl M.M., Hsu T.C.;
RT   "Establishment and biologic properties of human malignant melanoma
RT   cell lines grown in vitro.";
RL   Surg. Forum 18:78-79(1967).
//
RX   CelloPub=CLPUB00474;
RA   Romsdahl M.M.;
RT   "Establishment, characterization, and biological properties of human
RT   malignant melanoma cell lines grown in vitro.";
RL   Thesis PhD (1968), University of Texas at Houston, United States.
//
RX   PubMed=1127734; DOI=10.1093/jnci/54.5.1037;
RA   Liao S.-K., Dent P.B., McCulloch P.B.;
RT   "Characterization of human maligant melanoma cell lines. I. Morphology
RT   and growth characteristics in culture.";
RL   J. Natl. Cancer Inst. 54:1037-1044(1975).
//
RX   PubMed=5487065;
RA   Maul G.G., Romsdahl M.M.;
RT   "Ultrastructural comparison of two human malignant melanoma cell
RT   lines.";
RL   Cancer Res. 30:2782-2790(1970).
//